RPGRIP1 and retinal degeneration: Recent publications on successful gene therapy in mouse and dog models of RPGRIP1 retinal degeneration were published (Pawlyk et al., 2010; Lhériteau et al., 2014) and demonstrated preservation of retinal function in treated areas.